Log In
Print this Print this

Imgatuzumab (GA201, RO5083945) (RG7160)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized mAb against EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat metastatic non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today